List of Excipients in API vemurafenib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing vemurafenib
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Genentech Inc | ZELBORAF | vemurafenib | 50242-090 | CROSCARMELLOSE SODIUM | 2032-06-06 |
| Genentech Inc | ZELBORAF | vemurafenib | 50242-090 | FERRIC OXIDE RED | 2032-06-06 |
| Genentech Inc | ZELBORAF | vemurafenib | 50242-090 | HYDROXYPROPYL CELLULOSE | 2032-06-06 |
| Genentech Inc | ZELBORAF | vemurafenib | 50242-090 | HYPROMELLOSE ACETATE SUCCINATE 16070722 | 2032-06-06 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for vemurafenib
Excipient focus: CROSCARMELLOSE SODIUM
vemurafenib drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vemurafenib | 50242-090 |
| >Company | >Ingredient | >NDC |
vemurafenib drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
vemurafenib drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vemurafenib | 50242-090 |
| >Company | >Ingredient | >NDC |
vemurafenib drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
vemurafenib drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vemurafenib | 50242-090 |
| >Company | >Ingredient | >NDC |
vemurafenib drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 16070722
vemurafenib drug variants containing HYPROMELLOSE ACETATE SUCCINATE 16070722
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vemurafenib | 50242-090 |
| >Company | >Ingredient | >NDC |
vemurafenib drug variants not containing HYPROMELLOSE ACETATE SUCCINATE 16070722
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
vemurafenib drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vemurafenib | 50242-090 |
| >Company | >Ingredient | >NDC |
vemurafenib drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
vemurafenib drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vemurafenib | 50242-090 |
| >Company | >Ingredient | >NDC |
vemurafenib drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
vemurafenib drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vemurafenib | 50242-090 |
| >Company | >Ingredient | >NDC |
vemurafenib drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
vemurafenib drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vemurafenib | 50242-090 |
| >Company | >Ingredient | >NDC |
vemurafenib drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
